Combined evaluation of IGF-1 and IGFBP-3 as an index of efficacy and safety in growth hormone treated patients.

about

Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.

P2860

Q47187140-DC3BE510-2246-4404-962E-1384DCC3CAA8

P2860

Combined evaluation of IGF-1 and IGFBP-3 as an index of efficacy and safety in growth hormone treated patients.

Item

http://www.wikidata.org/entity/Q41293132

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Combined evaluation of IGF-1 a ...... owth hormone treated patients.

@en

type

Item

label

Combined evaluation of IGF-1 a ...... owth hormone treated patients.

@en

prefLabel

Combined evaluation of IGF-1 a ...... owth hormone treated patients.

@en

P1476

Combined evaluation of IGF-1 a ...... owth hormone treated patients.

@en

P2093

Gönül Öcal

http://www.w3.org/2001/XMLSchema#string

Merih Berberoğlu

http://www.w3.org/2001/XMLSchema#string

Pelin Bilir

http://www.w3.org/2001/XMLSchema#string

Zeynep Sıklar

http://www.w3.org/2001/XMLSchema#string

P2860

IGFs and human cancer: implications regarding the risk of growth hormone therapy.

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.

Optimizing gh therapy in adults and children.

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.

Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Should serum IGF-I concentrations be monitored routinely during growth hormone therapy?

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.

P304

240-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4274/JCRPE.V1I5.240

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49791959

http://www.w3.org/2001/XMLSchema#string

P698

21274301

http://www.w3.org/2001/XMLSchema#string

P932

3005747

http://www.w3.org/2001/XMLSchema#string

Combined evaluation of IGF-1 and IGFBP-3 as an index of efficacy and safety in growth hormone treated patients.

about

P2860

P2860

Combined evaluation of IGF-1 and IGFBP-3 as an index of efficacy and safety in growth hormone treated patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932